Risk Factors of Covid-19 Confirmed Died Patients in Dr. Kariadi Hospital: A Retrospective Study
Downloads
Centers for Disease Control and Prevention (CDC). Novel Coronavirus (2019-nCoV) [Internet]. 2020. [cited 2020 July 9]
Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS. MERS and Novel Coronavirus (Covid-19) Epidemics. The Newest and Biggest Global Health Threats: What Lessons have We Learned? International Journal of Epidemiology. 2020; 1–10. DOI: 10.1093/ije/dyaa033
Kahn LH. Commentary on: The SARS. MERS and Novel Coronavirus (Covid-19) Epidemics. The Newest and Biggest Global Health Threats: What Lessons have We Learned? A One Health Approach to Coronaviruses. International Journal of Epidemiology. 2020; 1–3 doi: 10.1093/ije/dya a071
The Health Ministry of Indonesia. The decree of health ministry No HK.01.07/Menkes/413/2020 about guidance for prevention of Coronavirus disease 2019 (Covid-19). Jakarta; 2020
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z. Clinical Course and Risk Factors for Mortality of Adult Inpatients with Covid-19 in Wuhan. China: a Retrospective Cohort Study. Lancet. 2020; 395(10229):1054-62. Epub 2020/03/15
Susilo A, Rumende MC, Pitoyo CW, Santoso WD, Yulianti M, Herikurniawan, Sinto R et al. Coronavirus Disease 2019: A literature review. Jurnal Penyakit Dalam Indonesia. 2020; 7(1): 45-67. doi: 10.7454/jpdi.v7i1.415
WHO. Transmision of SARS-CoV-2: Implication toward infection prevention awareness [Internet]. 2020. [cited 2020 July 22]. Available from: https://www.who.int/docs/defaultsource/searo/indone sia/covid19/transmisi-sars-cov-2implikasiuntuk terhadap-kewaspadaan-pencegahan-infeksi-pernya taan-keilmuan.pdf?sfvrsn=1534d7df_4
WHO. WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. 2020. [cited 2020 Juli 9]. Available from: https://covid19.who.int/ Accessed on 9 Juli 2020
Health Ministry. Covid-19 cases in Indonesia Dashboard [Internet]. 2020. [cited 2020 July 21]. Available from: https://www.kemkes.go.id/ article/view/20031900002/Dashboard-Data-KasusCOVID-19-di-Indonesia.html
Stand F, Jöckel K, Stang A. COVID‑19 and the Need of Targeted Inverse Quarantine. European Journal of Epidemiology. 2020; 35:339–340. doi: 10.1007/s10654020-00629-0
Du Z, Xu X, Wu Y, Wang L, Cowling BJ, Meyers AL. Serial Interval of COVID-19 among Publicly Reported Confirmed Cases. Emerging Infectious Diseases. 2020; 26 (6): 1341-1342. doi: 10.3201/eid2606.200357
The Health Ministry of Indonesia. Coronavirus Disease (Covid-19) prevention and control guidance. Jakarta: General directorate of disease prevention and control; 2020
Guo RF. A Flaw on a Meta-Analysis of Smoking and the Severity of Covid-19: The Association should have been Endorsed. Journal of Public Health. 2020; 42(3):653– 654. doi: 10.1093/pubmed/fdaa083
WHO. Scientific Brief: Smoking and Covid-19 [Internet].2020. [cited 2020 July 22]. Available from: https://www.who.int/newsroom/commentaries/detail/smo king-and-covid-19
Ardiaria M. The role of Vitamin D for influenza and Covid-19 prevention. JNH (Journal of Nutrition and Health). 2020; 8(2): 79-85.doi: 10.14710/jnh.8.2. 2020.79-85
Mahajan UV, Larkins-Pettigrew M. Racial demographics and COVID-19 Confirmed Cases and Deads: a Correlational Analysis of 2886 US Counties. Journal of Public Health. 2020; 1–4. DOI:10.1093/pubmed/fdaa070
Trias-Llimós S, Bilal U. Impact of the COVID-19 Pandemic on Life Expectancy in Madrid (Spain). Journal of Public Health. 2020; 1–2. doi: 10.1093/pubmed /fdaa087
Onder G, Rezza G, Brusaferro, S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID19 in Italy. JAMA. 2020; E1. doi:10.1001/jama .2020.4683
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical Course and Risk Factors for Mortality of Adult Inpatients with Covid-19 in Wuhan. China: a Retrospective Cohort Study. Lancet. 2020; 395: 1054-1062. doi: 10.1016/ S0140-6736(20)30566-3
Harlem G. Descriptive Analysis of Social Determinant Factors in Urban Communities Affected by COVID-19. Journal of Public Health. 2020; 1–4. doi:10.1093/pub med/fdaa078
Nie Y, Li J, Huang X, Guo W, Zhang X, Ma Y et al. Epidemiological and Clinical Characteristics of 671 COVID-19 Patients in Henan Province. China. International Journal of Epidemiology. 2020; 1–11. doi: 10.1093/ije/dyaa081
Lai CKC, Ng RWY, Wong MCS, Chong KC, Yeoh YK, Chen Z et al. Epidemiological Characteristics of the First 100 Cases of Coronavirus Disease 2019 (Covid-19) in Hong Kong Special Administrative Region. China. a City With a Stringent Containment Policy. International Journal of Epidemiology. 2020; 1–10. doi: 10.1093/ije /dyaa106
Gémes K, Talbäck M, Modig K, Ahlbom A, Berglund A, Feychting AA et al. Burden and Prevalence of Prognostic Factors for Severe COVID‑19 in Sweden. European Journal of Epidemiology. 2020;35:401–409. doi: https://doi.org/10.1007/s10654-020-00646-z
WHO. Advocacy Brief: Gender and Covid-19 [Internet]. 14 May 2020. [cited 2020 July 22]. Available from: https://www.who.int/publications/i/item/gender-andcovid-19
Alobuia WM, Dalva-Baird NP, Forrester JD, Bendavid E, Bhattacharya J, Kebebew E. Racial Disparities in Knowledge. Attitudes and Practices Related to COVID19 in the USA. Journal of Public Health. 2020; 1–9. doi:10.1093/pubmed/fdaa069
Mutambudzi M, Niedwiedz C, Macdonald EB, Leyland A, Mair F, Anderson J, Celis-Morales C, Cleland J, Forbes J, Gill J, Hastie C, Ho F, Jani B, Mackay DF, Nicholl B, O’Donnell C, Sattar N, Welsh P, Pell JP, Katikireddi SV, Demou E. Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occup. Environ. Med. 2020;0:1–8. doi:10.1136/oemed-2020-106731
Office for National Statistics. Coronavirus (COVID-19) related deaths by occupation, before and during lockdown, England and Wales: deaths registered between 9 March and 30 June 2020. Statistical bulletin. 2020;1-20
Prevention CfDCa. Interim US Guidance for Risk Assessment and Public Health Management of Persons with Potential Coronavirus Disease 2019 (COVID-19) Exposures: Geographic Risk and Contacts of Laboratory-confirmed Cases [Internet]. 2020. [cited 2020 July 23]. Available from: https://www.cdc.gov/ coronavirus/2019-ncov/php/risk-assessment.html
Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, Hosein Z, Padda I, Mangat J, Altaf M. Comorbidity and its Impact on Patients with COVID-19. SN Comprehensive Clinical Medicine. 2020. doi: 10.1007/s42399-020-00363
Byambasuren O, Cardona M, Bell K, Clark J, McLaws M-L, Glasziou P. Estimating the Extent of True Asymptomatic COVID-19 and Its Potential for Community Transmission: Systematic Review and Meta-Analysis.MedRxiv. 2020. doi:10.1101/2020.05.10.20097543
Qu G, Chen J, Huang G, Zhang M, Yu H, Zhu1 H, Chen L, Wang D, Pei B. A quantitative exploration of symptoms in COVID-19 patients: an observational cohort study. Int. J. Med. Sci. 2021; 18(4): 1082-1095. doi: 10.7150/ijms.53596
Oualha M, Bendavid M, Berteloot L, Corsia A, Lesage F, Vedrenne M et al. Severe and Fatal Forms of COVID-19 in Children. Archives de Pe´ diatrie. 2020; 27: 235–238. doi: 10.1016/j.arcped.2020.05.010.
Patel NA. Pediatric COVID-19: Systematic Review of the Literature. Am J Otolaryngol. 2020; 41:1-9. doi: 10.1016/j.amjoto.2020.102573
Copyright (c) 2021 Indonesian Journal of Tropical and Infectious Disease
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Indonesian Journal of Tropical and Infectious Disease (IJTID) is a scientific peer-reviewed journal freely available to be accessed, downloaded, and used for research. All articles published in the IJTID are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which is under the following terms:
Attribution — You must give appropriate credit, link to the license, and indicate if changes were made. You may do so reasonably, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
